Toor D, Degu A, Karimi P
Cancer Rep (Hoboken). 2025; 8(1):e70112.
PMID: 39806864
PMC: 11729749.
DOI: 10.1002/cnr2.70112.
Saatci D, Zhu C, Harnden A, Hippisley-Cox J
BMC Cancer. 2024; 24(1):718.
PMID: 38862882
PMC: 11167855.
DOI: 10.1186/s12885-024-12372-w.
Khan N, Khalid H, Mahar A, Aziz M, Kumar H
Int J Surg Case Rep. 2023; 114:109154.
PMID: 38141511
PMC: 10800688.
DOI: 10.1016/j.ijscr.2023.109154.
Lacroix M, Beauchemin H, Khandanpour C, Moroy T
Front Oncol. 2023; 13:1148936.
PMID: 37035206
PMC: 10081492.
DOI: 10.3389/fonc.2023.1148936.
Lu X, Liu Y, Liu R, Liu J, Yan X, Qian L
Front Oncol. 2023; 12:1063689.
PMID: 36620579
PMC: 9816660.
DOI: 10.3389/fonc.2022.1063689.
The Primary Outbreaks of Burkitt Lymphoma in the Oral Cavity. A Report of Two Cases, Review of the Literature and Dental Implications.
Kulczyk T, Daktera-Micker A, Biedziak B, Wziatek A, Bednarek-Rajewska K
Diagnostics (Basel). 2021; 11(12).
PMID: 34943595
PMC: 8700466.
DOI: 10.3390/diagnostics11122358.
Proteomic approaches to investigate gammaherpesvirus biology and associated tumorigenesis.
Chappell D, White M, Damania B
Adv Virus Res. 2021; 109:201-254.
PMID: 33934828
PMC: 8127003.
DOI: 10.1016/bs.aivir.2020.10.001.
Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable malignancies, 1990-2017.
Khan G, Fitzmaurice C, Naghavi M, Ahmed L
BMJ Open. 2020; 10(8):e037505.
PMID: 32868361
PMC: 7462312.
DOI: 10.1136/bmjopen-2020-037505.
Seroprevalence of Epstein-Barr virus among children and adults in Tehran, Iran.
Sharifipour S, Davoodi Rad K
New Microbes New Infect. 2020; 34:100641.
PMID: 32025310
PMC: 6997212.
DOI: 10.1016/j.nmni.2019.100641.
Burkitt lymphoma mimicking acute pancreatitis.
Bacchi L, Ucella I, Amancio T, Goncalves M, Palhares R, Siqueira S
Autops Case Rep. 2019; 2(3):5-11.
PMID: 31528574
PMC: 6735564.
DOI: 10.4322/acr.2012.020.
Adult Burkitt lymphoma: An institutional experience with a uniform chemotherapy protocol.
Patekar M, Gogia A, Tiwari A, Kumar L, Sharma A, Mallick S
South Asian J Cancer. 2018; 7(3):195-199.
PMID: 30112340
PMC: 6069339.
DOI: 10.4103/sajc.sajc_230_17.
Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.
Oosten L, Chamuleau M, Thielen F, de Wreede L, Siemes C, Doorduijn J
Ann Hematol. 2017; 97(2):255-266.
PMID: 29209924
PMC: 5754407.
DOI: 10.1007/s00277-017-3167-7.
Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences.
Kaymaz Y, Oduor C, Yu H, Otieno J, Ongecha J, Moormann A
Mol Cancer Res. 2017; 15(5):563-576.
PMID: 28465297
PMC: 5471630.
DOI: 10.1158/1541-7786.MCR-16-0305.
Burkitt lymphoma in adolescents and young adults: management challenges.
Dozzo M, Carobolante F, Donisi P, Scattolin A, Maino E, Sancetta R
Adolesc Health Med Ther. 2017; 8:11-29.
PMID: 28096698
PMC: 5207020.
DOI: 10.2147/AHMT.S94170.
Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010.
Khan G, Hashim M
Infect Agent Cancer. 2014; 9(1):38.
PMID: 25473414
PMC: 4253616.
DOI: 10.1186/1750-9378-9-38.
Disease patterns of pediatric non-Hodgkin lymphoma: A study from a developing area in Egypt.
Sherief L, Elsafy U, Abdelkhalek E, Kamal N, Youssef D, Elbehedy R
Mol Clin Oncol. 2014; 3(1):139-144.
PMID: 25469284
PMC: 4251264.
DOI: 10.3892/mco.2014.425.
The role of EBV in the pathogenesis of Burkitt's Lymphoma: an Italian hospital based survey.
Pannone G, Zamparese R, Pace M, Pedicillo M, Cagiano S, Somma P
Infect Agent Cancer. 2014; 9(1):34.
PMID: 25364378
PMC: 4216353.
DOI: 10.1186/1750-9378-9-34.
Seasonality of Burkitt's lymphoma in Uganda.
Muwazi L, Rwenyonyi C, Kutesa A, Kasangaki A, Kamulegeya A
J Oral Maxillofac Pathol. 2014; 18(Suppl 1):S6-S10.
PMID: 25364181
PMC: 4211240.
DOI: 10.4103/0973-029X.141323.
Burkittts lymphoma revisited: series of three cases with varied clinical presentation.
Chatterjee T, Gupta D, Bharadwaj R, Madan R
Indian J Hematol Blood Transfus. 2014; 30(Suppl 1):215-8.
PMID: 25332582
PMC: 4192217.
DOI: 10.1007/s12288-014-0334-z.
Medical history, lifestyle, family history, and occupational risk factors for sporadic Burkitt lymphoma/leukemia: the Interlymph Non-Hodgkin Lymphoma Subtypes Project.
Mbulaiteye S, Morton L, Sampson J, Chang E, Costas L, de Sanjose S
J Natl Cancer Inst Monogr. 2014; 2014(48):106-14.
PMID: 25174031
PMC: 4155458.
DOI: 10.1093/jncimonographs/lgu003.